---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-071399"
form_type: "8-K"
ticker: "NPCE"
cik: "0001528287"
company_name: "NeuroPace Inc"
filed_at: "2025-04-02T23:59:59+00:00"
generated_at: "2026-05-23T23:35:17.077098+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NeuroPace drops SEEG distribution deal to focus on core RNS System; reaffirms 2025 guidance

## Summary
- Terminated exclusive DIXI Medical SEEG distribution; wind down begins Q4 2025 through Q1 2026.
- CEO cites strategic refocus on RNS System; expects growth from Project CARE, indication expansions, AI software.
- Maintaining 2025 revenue guidance; no change to long-range plan of 20%+ CAGR and cash flow breakeven by end of 2027.
- Gross margin expected to improve: SEEG margin ~50% vs. RNS margin >78%.

## SEC filing metadata
- accession: 0001193125-25-071399
- form_type: 8-K
- ticker: NPCE
- cik: 0001528287
- company_name: NeuroPace Inc
- filed_at: 2025-04-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1528287/000119312525071399/0001193125-25-071399-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1528287/000119312525071399/d949067d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-071399
- JSON: https://secwatch.observer/filing/0001193125-25-071399.json
- Plain text: https://secwatch.observer/filing/0001193125-25-071399.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.